20 Apr, 2023 Cross-border considerations for privacy in clinical trials - At the Intersection of Sciences and Law Podcast Series By James Clark Paula Gonzalez de Castejón Llano-Ponte David Kopans In this episode of At the Intersection of Sciences and Law Podcast Series, in light of the recent publication of our Cross-border Guide...
17 Apr, 2023 ESG Issues: Clinical Trials and Diversity (Racial Bias in Medical Technology) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Abi Ketheeswaran Sharon Zhang +2 more... Show less ESG is increasingly a primary focus for companies and consumers alike. Across all industries, companies are under immense scrutiny from...
07 Mar, 2022 HealthTech - Shifting Landscapes Series (Part 1): Overview By Hannah Gardiner HealthTech: Trends and Challenges In a recent internal webinar, DLA Piper and Global Data looked into the shifting landscape of...
26 Jan, 2022 Initiative launched to accelerate EU clinical trials (ACT EU) By Lyndsey Hudson Accelerating Clinical Trials in the EU (ACT EU) was launched a few days ago, with the aim of transforming the way in which clinical...
25 Jan, 2022 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include significant updates to several...
05 Oct, 2021 Update: DLA Piper Global COVID-19 Vaccine Guide for Employers By Marco de Morpurgo DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include the additions of Sweden and...
09 Sep, 2021 mRNA Technology: A New Approach to Therapeutics (podcast) By Lisa Haile For decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice...
25 May, 2021 Launch of DLA Piper Global COVID-19 Vaccine Guide for Employers By Pilar Menor Marco de Morpurgo As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues...
11 May, 2021 EC's variations to the terms of marketing authorisations - another COVID-19 dictated reform By Mariana Ricardo As countries in the European Union (EU) take baby steps towards reopening businesses and ramp up COVID-19 vaccination, the pandemic and...
22 Feb, 2021 Portuguese VAT exemption to transfers of medical devices for in-vitro diagnosis of COVID-19, its vaccines and related provision of services By Inês Santana Metello Portugal published Law no. 4-C/2021, which transposes the Directive (EU) 2020/2020 from the 7th of December 2020, as regards temporary...
16 Feb, 2021 An ever-changing landscape - European regulator looks to speed up authorisation process for modified vaccines addressing COVID-19 variants By Kate Black At a time where drug makers are taking action to develop modified versions of their vaccines in order to address the evolving variants of...
10 Feb, 2021 The emergence of strategic assets in the health sector: Portugal takes the final step to create a National Medicines Laboratory By Mariana Ricardo Inês Santana Metello When the Covid-19 pandemic hit Europe in 2020, the Portuguese Government took the opportunity to establish the health sector as a...